Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|October 3, 2022
Th17-cells in depression: Implication in multiple sclerosisMikhail Melnikov, Anna LopatinaBrain Sciences|May 24, 2020
Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of StudiesAlexey Boyko, Mikhail MelnikovInternational Journal of Molecular Sciences|June 2, 2021
Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?Mikhail Melnikov, Mikhail Pashenkov, Alexey BoykoInternational Immunopharmacology|June 22, 2024
The role of dopamine in the modulation of monocyte-induced Th17- and Th1-immune response in multiple sclerosisOlga Belousova, Anna Lopatina, Mikhail MelnikovNeuroimmunomodulation|October 7, 2016
The Role of Biogenic Amines in the Regulation of Interaction between the Immune and Nervous Systems in Multiple SclerosisAlexey Boyko, Mikhail Melnikov, Rustam Zhetishev, et al.Multiple Sclerosis and Related Disorders|February 18, 2018
The influence of biogenic amines on Th17-mediated immune response in multiple sclerosisMikhail Melnikov, Vladimir Rogovskii, Alexey Boyko, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 24, 2019
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell FunctionsMikhail Melnikov, Vladimir Rogovskii, Alexey Boykо, et al.Multiple Sclerosis and Related Disorders|August 3, 2023
The role of biogenic amines in the modulation of monocytes in autoimmune neuroinflammationOlga Belousova, Anna Lopatina, Ulyana Kuzmina, et al.Materials (Basel, Switzerland)|May 28, 2022
Nanoparticles of Bioactive Metals/Metal Oxides and Their Nanocomposites with Antibacterial Drugs for Biomedical ApplicationsTatyana Shabatina, Olga Vernaya, Aleksei Shumilkin, et al.Journal of Neuroimmunology|March 6, 2016
The role of dopamine in modulation of Th-17 immune response in multiple sclerosisMikhail Melnikov, Olga Belousova, Vladimir Murugin, et al.Pageof 3